GlobeNewswire 2021-08-05 Amarin Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update
GlobeNewswire 2021-07-30 Craig Granowitz, M.D., Ph.D. Joins Lexicon as Senior Vice President and Chief Medical Officer
GlobeNewswire 2021-07-15 Amarin to Report Second Quarter and Six Month 2021 Financial Results and Host Conference Call on Aug...
GlobeNewswire 2021-06-02 Further Insights into Mechanism of Action of Icosapent Ethyl and Its Unique Form of Eicosapentaenoic...
GlobeNewswire 2021-05-20 CinCor Pharma Announces Appointments of Three Experienced Independent Members to Its Board of Direct...
GlobeNewswire 2021-05-18 Amarin to Present at Two Investor Conferences in June 2021
GlobeNewswire 2021-05-17 Amarin Highlights Multiple Scientific Findings for VASCEPA® (Icosapent Ethyl) and Its Unique Active ...
GlobeNewswire 2021-05-15 REDUCE-IT® Heart Failure Analyses by VASCEPA® (Icosapent Ethyl)-Driven Serum Eicosapentaenoic Acid (...
GlobeNewswire 2021-05-10 Matinas BioPharma Reports First Quarter 2021 Financial Results and Operational Highlights
GlobeNewswire 2021-05-04 Clinical Data and Other Research Results Regarding VASCEPA® (Icosapent Ethyl) and Its Unique Active ...
GlobeNewswire 2021-04-29 Amarin Reports First Quarter 2021 Financial Results and Provides Business Update
GlobeNewswire 2021-04-29 Amarin Announces Planned Retirement of Joseph T. Kennedy, EVP, General Counsel
GlobeNewswire 2021-04-22 Amarin Receives Great Britain Marketing Authorization for VAZKEPA from the Medicines and Healthcare ...
GlobeNewswire 2021-04-20 Amarin to Report First Quarter Results and Host Conference Call on April 29, 2021
GlobeNewswire 2021-04-17 VASCEPA® (Icosapent Ethyl) Reported to Impact Vulnerable Coronary Plaque Features in New Analyses of...
GlobeNewswire 2021-04-12 Amarin Announces CEO Succession Plan
GlobeNewswire 2021-04-06 Amarin Commences Commercial Initiatives for VAZKEPA in European Union Following Recent Regulatory Ap...
GlobeNewswire 2021-03-30 Amarin Receives European Commission (EC) Approval for VAZKEPA to Reduce Cardiovascular Risk
GlobeNewswire 2021-03-29 Fifteen Medical Societies Now Recommend Icosapent Ethyl to Reduce Cardiovascular Risk, Further Suppo...
GlobeNewswire 2021-03-29 Matinas BioPharma Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highli...
GlobeNewswire 2021-03-17 VASCEPA® (Icosapent Ethyl) Found in Prespecified and Post Hoc Analyses to Significantly Reduce Strok...
GlobeNewswire 2021-02-25 Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
GlobeNewswire 2021-02-18 Amarin to Present at Two Upcoming Investor Conferences
GlobeNewswire 2021-02-17 Amarin to Report Fourth Quarter and Full Year 2020 Results and Host Conference Call on February 25, ...
GlobeNewswire 2021-02-09 Amarin Provides Update on VASCEPA® (Icosapent Ethyl) Regulatory Review Processes in Mainland China a...